SCNI
Scinai Immunotherapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.72
−3.80%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$8.50
- Revenue estimate
- $494.6K
Latest reported
- Last report date
- Aug 26, 2026
- EPS actual
- -$0.74
- EPS estimate
- —
- Revenue actual
- $467.9K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -9775.9%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 26, 2026 | — | -$0.74 | — | $467.9K |
| Jun 10, 2026 | — | $0.94 | — | $487.7K |
| Dec 2, 2025 | — | -$1.33 | — | $277.3K |
| Sep 2, 2025 | — | -$3.57 | — | $115.5K |
| May 7, 2025 | — | -$10 | — | $56.5K |
| Nov 22, 2024 | — | $8.40 | — | $44.2K |
| Aug 15, 2024 | — | -$3.57 | — | $75.4K |
| May 15, 2024 | -$0.62 | -$240 | Miss -38609.68% | — |
| Oct 31, 2023 | -$0.99 | -$6.60 | Miss -566.67% | — |
| Aug 11, 2023 | -$0.91 | -$1.11 | Miss -21.98% | — |
| May 15, 2023 | -$22 | -$1.20 | Beat 94.55% | — |
| Sep 30, 2022 | -$1.00 | $0.00 | Beat 100.04% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026